Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[@PsychedVantage](/creator/twitter/PsychedVantage)
"When/if Pharma makes another move on short acting psychedelics which program is their most likely target $CYBN $ATAI $GHRS"  
[X Link](https://x.com/PsychedVantage/status/1972678347759980830) [@PsychedVantage](/creator/x/PsychedVantage) 2025-09-29T15:02Z 1504 followers, XXX engagements


"@c2412345 @Matt_vlietstra @Thegaucher1 Ya I sold out for a loss. Only individual stocks I hold rn are $ATAI $CMPS $ANRO and $VTGN. I could potentially see myself re-entering $CYBN at some point. We shall see. -Jake"  
[X Link](https://x.com/PsychedVantage/status/1976307133671968971) [@PsychedVantage](/creator/x/PsychedVantage) 2025-10-09T15:21Z 1505 followers, XXX engagements


"AbbVie acquired Gilgameshs GM-2505 (bretisilocin) in a deal worth up to $1.2B. The upfront wasnt disclosed. Whats your estimate for the upfront payment (No royalties mentioned; GM-2505 has been IV in trials with an IM formulation planned) $CMPS $MNMD $CYBN $ATAI $GHRS"  
[X Link](https://x.com/PsychedVantage/status/1962621388818112828) [@PsychedVantage](/creator/x/PsychedVantage) 2025-09-01T20:59Z 1510 followers, 1266 engagements


"Updated neuropsychiatry drug development portfolio allocation (Individual + Roth IRA) Today I sold around XX% of my $ATAI position and for a simple reason: Not only was $ATAI very overweight in my neuropsychiatry drug development portfolio it was starting to make up an uncomfortably large share of my overall net worth. (I still think this stock has a lot of upside potential in the short medium and longterm/not financial or investment advice). As always this is not investment advice. I share to stay transparent and spark conversation in the community. -Jake"  
[X Link](https://x.com/PsychedVantage/status/1970591031256052027) [@PsychedVantage](/creator/x/PsychedVantage) 2025-09-23T20:48Z 1505 followers, 3358 engagements


"Cybin Highlights Neuropsychiatry Platform and Upcoming Clinical Milestones $CYBN"  
[X Link](https://x.com/PsychedVantage/status/1970595295609197002) [@PsychedVantage](/creator/x/PsychedVantage) 2025-09-23T21:05Z 1515 followers, XXX engagements


"Some personal thoughts/opinions/predictions (I reserve the right to be wrong): $CMPS $MNMD $CYBN $ATAI $GHRS $CMPS COMP005 XX week data could underwhelm investors (potentially being shared in Q1 2026 though no official guidance from $CMPS yet as far as Im aware). As I have shared many times I am much more bullish on COMP006 data. BPL-003 will eventually be granted BTD. $ATAI needs more cash. Will they partner up Raise a new round What valuation will healthcare investors be comfortable with $CMPS head start in the space may be more than some anticipated. With more companies running large phase"  
[X Link](https://x.com/PsychedVantage/status/1971303340492366255) [@PsychedVantage](/creator/x/PsychedVantage) 2025-09-25T19:58Z 1505 followers, 2911 engagements


"Although 5-MeO-DMT is in later stages of development and has shown a lot of promise: for the treatment of depression/anxiety specifically I am most excited about the potential of NN-DMT. Great to see $ATAI and $CYBN using two-dose induction models in their phase X trials in TRD and GAD (with co-morbid depression allowed). Most optimistic about the potential of 5-MeO-DMT for substance use disorders. (Not included on list)-Does atai/Beckley find a buyer for ELE-101 I like the idea of a short-acting psilocybin-like candidate (Perhaps a better tolerated psychedelic when compared to NN/5-MeO-DMT)"  
[X Link](https://x.com/PsychedVantage/status/1972678349928419442) [@PsychedVantage](/creator/x/PsychedVantage) 2025-09-29T15:02Z 1504 followers, XXX engagements


"Updated neuropsychiatry drug development portfolio allocation (Individual + Roth IRA) I cut losses with $CYBN and spread money around to $ATAI $CMPS $VTGN $NEUP (new position) $VOO and $VTI As always this is not investment advice. I share to stay transparent and spark conversation in the community. -Jake"  
[X Link](https://x.com/PsychedVantage/status/1973055674968908280) [@PsychedVantage](/creator/x/PsychedVantage) 2025-09-30T16:01Z 1504 followers, 3132 engagements


"I like $MNMD. Just like the other names I currently hold more. I could see myself potentially buying some in the future. Yeah to me at least a bet on $CYBN is a bet that they partner up for both CYB003 and CYB004 or get bought out. I think CYB004 is a special program excited to see data when it is released in Q1 2026. Not quite convinced yet that CYB003 is that much differentiated from COMP360. -Jake"  
[X Link](https://x.com/PsychedVantage/status/1976314172267704453) [@PsychedVantage](/creator/x/PsychedVantage) 2025-10-09T15:49Z 1515 followers, XXX engagements


"Cybin to Participate in the Cantor Global Healthcare Conference 2025 $CYBN"  
[X Link](https://x.com/PsychedVantage/status/1963203236166299912) [@PsychedVantage](/creator/x/PsychedVantage) 2025-09-03T11:31Z 1515 followers, 1030 engagements


"The Complete Response Letter (CRL) issued to Lykos Therapeutics is now publicly available $CMPS $MNMD $CYBN $ATAI $GHRS"  
[X Link](https://x.com/PsychedVantage/status/1963635185678774541) [@PsychedVantage](/creator/x/PsychedVantage) 2025-09-04T16:08Z 1515 followers, 2397 engagements


"Cybin Completes Enrollment in Phase X Study Evaluating CYB004 for the Treatment of Generalized Anxiety Disorder $CYBN"  
[X Link](https://x.com/PsychedVantage/status/1965015235108176100) [@PsychedVantage](/creator/x/PsychedVantage) 2025-09-08T11:31Z 1515 followers, 1056 engagements


"Updates: Chickened out and sold $NEUP for a XX% gain. Not investment advice. -Jake"  
[X Link](https://x.com/PsychedVantage/status/1975557556509782023) [@PsychedVantage](/creator/x/PsychedVantage) 2025-10-07T13:43Z 1521 followers, XXX engagements


"atai Life Sciences Announces Proposed Public Offering of Common Shares $ATAI"  
[X Link](https://x.com/PsychedVantage/status/1978917961189490898) [@PsychedVantage](/creator/x/PsychedVantage) 2025-10-16T20:16Z 1521 followers, 2150 engagements


"Indeed. Very exciting news. 🐸 Interested to see the pricing of the proposed public offering. $ATAI"  
[X Link](https://x.com/PsychedVantage/status/1978931365769892063) [@PsychedVantage](/creator/x/PsychedVantage) 2025-10-16T21:09Z 1521 followers, 2393 engagements


"atai Life Sciences Announces Pricing of Public Offering of Common Shares $ATAI"  
[X Link](https://x.com/PsychedVantage/status/1979012977836601377) [@PsychedVantage](/creator/x/PsychedVantage) 2025-10-17T02:33Z 1521 followers, 3045 engagements


"Close Priced at $XXXX. Great to see $ATAI raising at this valuation curious to see which investors participated when that list comes out"  
[X Link](https://x.com/PsychedVantage/status/1979014988116181188) [@PsychedVantage](/creator/x/PsychedVantage) 2025-10-17T02:41Z 1521 followers, 2503 engagements


"@C_Angermayer @atai_life Congratulations @C_Angermayer and to the entire team at @atai_life and @BeckleyPsytech"  
[X Link](https://x.com/PsychedVantage/status/1979166155957772600) [@PsychedVantage](/creator/x/PsychedVantage) 2025-10-17T12:42Z 1521 followers, XXX engagements


"AbbVie Completes Acquisition of Gilgamesh Pharmaceuticals' Bretisilocin"  
[X Link](https://x.com/PsychedVantage/status/1979194096510976096) [@PsychedVantage](/creator/x/PsychedVantage) 2025-10-17T14:33Z 1521 followers, XXX engagements


"$MNMD surpasses $X billion dollar market cap"  
[X Link](https://x.com/PsychedVantage/status/1979271935524556879) [@PsychedVantage](/creator/x/PsychedVantage) 2025-10-17T19:42Z 1521 followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@PsychedVantage "When/if Pharma makes another move on short acting psychedelics which program is their most likely target $CYBN $ATAI $GHRS"
X Link @PsychedVantage 2025-09-29T15:02Z 1504 followers, XXX engagements

"@c2412345 @Matt_vlietstra @Thegaucher1 Ya I sold out for a loss. Only individual stocks I hold rn are $ATAI $CMPS $ANRO and $VTGN. I could potentially see myself re-entering $CYBN at some point. We shall see. -Jake"
X Link @PsychedVantage 2025-10-09T15:21Z 1505 followers, XXX engagements

"AbbVie acquired Gilgameshs GM-2505 (bretisilocin) in a deal worth up to $1.2B. The upfront wasnt disclosed. Whats your estimate for the upfront payment (No royalties mentioned; GM-2505 has been IV in trials with an IM formulation planned) $CMPS $MNMD $CYBN $ATAI $GHRS"
X Link @PsychedVantage 2025-09-01T20:59Z 1510 followers, 1266 engagements

"Updated neuropsychiatry drug development portfolio allocation (Individual + Roth IRA) Today I sold around XX% of my $ATAI position and for a simple reason: Not only was $ATAI very overweight in my neuropsychiatry drug development portfolio it was starting to make up an uncomfortably large share of my overall net worth. (I still think this stock has a lot of upside potential in the short medium and longterm/not financial or investment advice). As always this is not investment advice. I share to stay transparent and spark conversation in the community. -Jake"
X Link @PsychedVantage 2025-09-23T20:48Z 1505 followers, 3358 engagements

"Cybin Highlights Neuropsychiatry Platform and Upcoming Clinical Milestones $CYBN"
X Link @PsychedVantage 2025-09-23T21:05Z 1515 followers, XXX engagements

"Some personal thoughts/opinions/predictions (I reserve the right to be wrong): $CMPS $MNMD $CYBN $ATAI $GHRS $CMPS COMP005 XX week data could underwhelm investors (potentially being shared in Q1 2026 though no official guidance from $CMPS yet as far as Im aware). As I have shared many times I am much more bullish on COMP006 data. BPL-003 will eventually be granted BTD. $ATAI needs more cash. Will they partner up Raise a new round What valuation will healthcare investors be comfortable with $CMPS head start in the space may be more than some anticipated. With more companies running large phase"
X Link @PsychedVantage 2025-09-25T19:58Z 1505 followers, 2911 engagements

"Although 5-MeO-DMT is in later stages of development and has shown a lot of promise: for the treatment of depression/anxiety specifically I am most excited about the potential of NN-DMT. Great to see $ATAI and $CYBN using two-dose induction models in their phase X trials in TRD and GAD (with co-morbid depression allowed). Most optimistic about the potential of 5-MeO-DMT for substance use disorders. (Not included on list)-Does atai/Beckley find a buyer for ELE-101 I like the idea of a short-acting psilocybin-like candidate (Perhaps a better tolerated psychedelic when compared to NN/5-MeO-DMT)"
X Link @PsychedVantage 2025-09-29T15:02Z 1504 followers, XXX engagements

"Updated neuropsychiatry drug development portfolio allocation (Individual + Roth IRA) I cut losses with $CYBN and spread money around to $ATAI $CMPS $VTGN $NEUP (new position) $VOO and $VTI As always this is not investment advice. I share to stay transparent and spark conversation in the community. -Jake"
X Link @PsychedVantage 2025-09-30T16:01Z 1504 followers, 3132 engagements

"I like $MNMD. Just like the other names I currently hold more. I could see myself potentially buying some in the future. Yeah to me at least a bet on $CYBN is a bet that they partner up for both CYB003 and CYB004 or get bought out. I think CYB004 is a special program excited to see data when it is released in Q1 2026. Not quite convinced yet that CYB003 is that much differentiated from COMP360. -Jake"
X Link @PsychedVantage 2025-10-09T15:49Z 1515 followers, XXX engagements

"Cybin to Participate in the Cantor Global Healthcare Conference 2025 $CYBN"
X Link @PsychedVantage 2025-09-03T11:31Z 1515 followers, 1030 engagements

"The Complete Response Letter (CRL) issued to Lykos Therapeutics is now publicly available $CMPS $MNMD $CYBN $ATAI $GHRS"
X Link @PsychedVantage 2025-09-04T16:08Z 1515 followers, 2397 engagements

"Cybin Completes Enrollment in Phase X Study Evaluating CYB004 for the Treatment of Generalized Anxiety Disorder $CYBN"
X Link @PsychedVantage 2025-09-08T11:31Z 1515 followers, 1056 engagements

"Updates: Chickened out and sold $NEUP for a XX% gain. Not investment advice. -Jake"
X Link @PsychedVantage 2025-10-07T13:43Z 1521 followers, XXX engagements

"atai Life Sciences Announces Proposed Public Offering of Common Shares $ATAI"
X Link @PsychedVantage 2025-10-16T20:16Z 1521 followers, 2150 engagements

"Indeed. Very exciting news. 🐸 Interested to see the pricing of the proposed public offering. $ATAI"
X Link @PsychedVantage 2025-10-16T21:09Z 1521 followers, 2393 engagements

"atai Life Sciences Announces Pricing of Public Offering of Common Shares $ATAI"
X Link @PsychedVantage 2025-10-17T02:33Z 1521 followers, 3045 engagements

"Close Priced at $XXXX. Great to see $ATAI raising at this valuation curious to see which investors participated when that list comes out"
X Link @PsychedVantage 2025-10-17T02:41Z 1521 followers, 2503 engagements

"@C_Angermayer @atai_life Congratulations @C_Angermayer and to the entire team at @atai_life and @BeckleyPsytech"
X Link @PsychedVantage 2025-10-17T12:42Z 1521 followers, XXX engagements

"AbbVie Completes Acquisition of Gilgamesh Pharmaceuticals' Bretisilocin"
X Link @PsychedVantage 2025-10-17T14:33Z 1521 followers, XXX engagements

"$MNMD surpasses $X billion dollar market cap"
X Link @PsychedVantage 2025-10-17T19:42Z 1521 followers, XXX engagements

creator/twitter::1461655010958315520/posts
/creator/twitter::1461655010958315520/posts